Deutsche Bank Upgrades Intuitive Machines: Space Stock Set to Soar
Deutsche Bank analyst upgrades Intuitive Machines to Buy with $18 price target, citing "strong catalysts" and discount to space peers. Major contracts could drive gains.
NOTRELOAD AI
Barclays Dramatically Cuts Rating on AST SpaceMobile Despite Strong Potential
Barclays downgrades AST SpaceMobile from Overweight to Underweight, maintaining $60 price target. Stock valuation concerns overshadow promising direct-to-cellular technology prospects.
Trump Vows Sharp Cut to Ozempic Price, Sending Novo Nordisk Shares Tumbling
President Trump signaled major price reductions for Novo Nordisk's Ozempic, potentially lowering costs to $150. This announcement, made amid ongoing drug price negotiations, caused significant drops in pharma stock prices.
Disc Medicine Gets FDA Fast-Track Voucher for Rare Skin Disease Treatment
Disc Medicine receives FDA's Commissioner's National Priority Voucher for bitopertin, accelerating approval timeline to 1-2 months for EPP patients who suffer severe sun sensitivity.
Loan Fraud and 'Cockroach' Concerns Slam Regional Bank Stocks as Credit Cracks Emerge
Shares of Zions Bancorp and Western Alliance tumbled after disclosing loan fraud tied to distressed commercial mortgages. This adds to wider concerns about asset quality, following bankruptcies like Tricolor and First Brands, and raises questions about regional lenders' risk exposure.
Trump to Announce New IVF Access Initiative to Lower Fertility Treatment Costs
President Trump announces new employer-focused IVF initiative to reduce fertility treatment costs. Voluntary program aims to expand workplace coverage options.